NeurAxis PENFS IB-Stim Technology: A Drug-Free, Non-Invasive Way To Effectively Treat Pediatric Functional Abdominal Pain Associated With IBS ($NRXS) -October 04, 2023 at 05:09 am EDT

NeurAxis Inc. proves that a smallcap biotech can deliver best-in-market care. That's more than great news for NRXS from a revenue perspective and for its patients from a treatment point of view. It...

Related Keywords

Boston ,Massachusetts ,United States ,Rob Goldman ,Jack Enterprises ,Hawk Point Media Group Llc ,Neuraxis Inc ,Boston Scientific Corp ,Goldman Smallcap Research ,Functional Abdominal Pain ,Irritable Bowel Syndrome ,Smallcap Research ,Immediate Post Concussion Assessment ,Post Concussion Symptom Scale ,Balance Error Scoring Symptom ,Big Pharma ,Point Media Group ,Eyed Jack Enterprises ,Private Securities Litigation Reform Act ,Hawk Point ,Markets ,